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Introduction
The growth and maintenance of the axon is dependent on a 
continuous array of microtubules that extends from the cell body 
of the neuron into the growth cone. Individual microtubules 
  assume a variety of lengths within the array, ranging from <1 to 
>100 μm (Yu and Baas, 1994). Very short microtubules are able 
to move rapidly and in both directions (Wang and Brown, 2002). 
In contrast, the longer microtubules in the axon are essentially 
immobile (Ma et al., 2004; Ahmad et al., 2006). Twice as many 
short microtubules move in the anterograde direction, presum-
ably to ensure that more tubulin enters the axon than is moved 
back to the cell body. In addition to supplying tubulin for axonal 
growth, mobility within the microtubule array promotes the 
morphological plasticity underlying events such as growth-cone 
motility and branch formation (Yu and Baas, 1994; Dent et al., 
1999). The longer microtubules are important too because they 
act as compression-bearing struts that prevent the axon from 
  retracting under the myosin-II–based contractile forces imposed 
on the cortical actin (Myers et al., 2006b). We have proposed a 
model whereby the same molecular motors that transport the 
short microtubules impinge upon the long microtubules to regu-
late the degree to which they can resist the myosin-based con-
tractile forces (Baas et al., 2006).
We have begun to study the panoply of microtubule-based 
motors that generate forces against long and short microtubules. 
We have found that if we deplete cytoplasmic dynein or if we 
depolymerize actin fi  laments, the frequency of anterograde 
  microtubule transport is reduced by about half (Hasaka et al., 
2004; He et al., 2005). These results are consistent with a sce-
nario in which short microtubules move anterogradely via a 
“sliding fi  lament” mechanism in which the cargo domain of the 
motor interacts (indirectly) with actin fi  laments (Pfi  ster, 1999; 
Myers et al., 2006a). The motor domain is then available to 
transport the short microtubules. Consistent with our model for 
long and short microtubules, depletion of cytoplasmic dynein 
also renders the long microtubules less capable of resisting the 
myosin-II–based contractile forces that cause the axon to retract 
(Ahmad et al., 2000; Myers et al., 2006a). The fact that not all 
of the mobility within the microtubule array depends on cyto-
plasmic dynein indicates that there are other participating mo-
tors, presumably kinesins.
The relevant kinesins are the so-called mitotic kinesins, 
which generate forces between adjacent microtubules rather than 
between microtubules and membranous cargo (Dent et al., 1999). 
We have shown that many of these specialized kinesins continue 
to be expressed in terminally postmitotic neurons (Sharp et al., 
1997; Ferhat et al., 1998; Buster et al., 2003). We are particularly 
interested in kinesin-5 (also known as Eg5), which forms homo-
tetramers consisting of two sets of antiparallel motor domains 
(Kashina et al., 1996). In the mitotic spindle, the primary func-
tion of kinesin-5 is to maintain spindle bipolarity by generating 
centrosome-directed forces between antiparallel microtubules in 
the midzone (Blangy et al., 1995; Sharp et al., 1999a,b; Kapitein 
et al., 2005). In neurons, pharmacological inhibition of kinesin-5 
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results in longer axons (Haque et al., 2004; Yoon et al., 2005), 
suggesting a key role for this motor in the development of the 
nervous system. In the present study, we have investigated the 
underlying mechanisms by which kinesin-5 infl  uences the devel-
opment of the axon.
Results
Although monastrol (the drug used in the earlier studies on neu-
rons; Haque et al., 2004; Yoon et al., 2005) is quite specifi  c for 
kinesin-5 (Kapoor et al., 2000; Maliga et al., 2002; Kwok et al., 
2006; Maliga and Mitchison, 2006), we wished to pursue an 
  additional approach that would deplete kinesin-5 rather than 
  inhibit it. For this we used siRNA, which has been shown to 
be highly effective at depleting kinesin-5 from other cell types 
(Weil et al., 2002). For the current experiments, rat sympa-
thetic neurons were transfected with 10 μM siRNA (control or 
kinesin-5), plated densely on plastic dishes, and then allowed 
time for the protein to be depleted. As determined by Western 
blotting, 3 d after transfection was suffi  cient time to deplete 
over 95% of the kinesin-5 protein from the neurons (Fig. 1 A). 
The neurons were then replated at a lower density onto glass 
coverslips treated with polylysine and laminin, and allowed to 
grow axons anew. For some studies, we also performed side-by-
side monastrol experiments.
Effects of kinesin-5 depletion 
on axonal morphology
For evaluation of the effects of siRNA-based depletion of kinesin-5 
on axonal morphology, neurons were chosen randomly and then 
imaged at successive time points beginning 1 h after plating, and 
continuing every 2 h thereafter until 7 h. Although at the 1 h time 
point there were very few neurons that had extended axons in ei-
ther the control or experimental groups; analyses of mean axonal 
length at 3, 5, and 7 h all revealed signifi  cant increases in the ex-
perimental neurons. Specifi  cally, quantifi  cation of axonal length 
revealed a 4.3-fold increase in mean axonal lengths at all three 
time points, a change that was statistically signifi  cant (3 h, P < 
0.008; 5 h, P < 0.002; 7 h, P < 0.0003; two-tailed t test; Fig. 1 B). 
These differences (Fig. 1, C and D) were comparable to those 
  obtained in parallel experiments using monastrol (see Fig. 8).
In addition to being longer, the experimental axons were 
also more branched than the control axons (Fig. 2, A and B). For 
quantifi  cation of this effect, total branch numbers were normal-
ized to total axonal length, so that the values were comparable 
between control and kinesin-5–depleted neurons (control, n = 27; 
kinesin-5 siRNA, n = 37). Statistical analyses of axonal 
branching data revealed a signifi  cant increase in branching fre-
quency of kinesin-5–depleted neurons to levels nearly four times 
higher than controls (Fig. 2 C). When branching frequency was 
quantifi  ed based on the location of the branches, a statistically 
Figure 1.  Kinesin-5 depletion results in increased axonal length. (A) Western blot showing kinesin-5 protein levels in cultured sympathetic neurons treated 
with control siRNA and kinesin-5 siRNA. The bottom panel shows the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) loading control for both pro-
tein samples. (B) Quantiﬁ  cation of mean axonal outgrowth reveals signiﬁ  cantly longer axons of kinesin-5–depleted neurons at all time points observed, 
with a 4.3-fold mean increase in axonal length (mean ± SEM; 3 h, control = 21.3 ± 6.45 μm, experimental = 82.8 ± 19.7 μm; 5 h, control = 71.8 ± 
20.0 μm, experimental = 335 ± 66.8 μm; 7 h, control = 187 ± 37.1 μm, experimental = 774 ± 120 μm) (control siRNA, n = 17; kinesin-5 siRNA, 
n = 21; *, P < 0.01). (C) Fluorescence images of kinesin-5 immunostaining in control siRNA (top) and kinesin-5 siRNA–treated neurons (bottom). The cor-
responding microtubule staining for these two cells is shown in the panels on the right. (D) DIC images of a control siRNA neuron taken at 3, 5, and 7 h after 
replating. (E) DIC images of a kinesin-5–depleted neuron at 3, 5, and 7 h after replating revealed the notable increases in axonal length quantiﬁ  ed in B. 
Bars, 20 μm. KINESIN-5 IS A BRAKE ON AXONAL MICROTUBULES • MYERS AND BAAS 1083
signifi  cant increase in branching frequency was identifi  ed in 
 kinesin-5–depleted neurons at all branch loci (Fig. 2 D). In neurons 
depleted of kinesin-5, primary branch frequency was increased to 
217% of controls (P < 0.02; n = 14), secondary branch frequency 
was increased to 200% of controls (P < 0.03; n = 14), and ter-
tiary branch frequency was elevated to 298% of control neurons 
(P < 0.03; n = 12). There were no quaternary branches observed 
in the control siRNA group of neurons during the observation 
time period (n = 12). The change between control and kinesin-5 
siRNA was found to be statistically signifi  cant (P < 0.007).
We next investigated whether the kinesin-5–depleted axons 
differed from controls in their propensity to retract in response 
to physiological cues. For this, we used noc-7 (a donor of nitric 
oxide and potent inducer of axonal retraction; Ernst et al., 2000; 
He et al., 2002). After allowing neurons depleted of kinesin-5 to 
undergo 12–16 h of axonal growth, differential interference 
contrast (DIC) images were taken of individual neurons whose 
axons were >100 μm, followed by treatment with 0.3 mM 
noc-7 for 30 min. These same neurons were then relocated and 
imaged once again, and the before-and-after images were ana-
lyzed for mean differences in axonal length. Quantifi  cation of 
mean distance retracted revealed that the axons of neurons 
transfected with control siRNA underwent signifi  cantly greater 
distances of retraction than the axons of neurons depleted of 
  kinesin-5 (control siRNA, n = 54; kinesin-5 siRNA, n = 55). In 
some cases, the axons of the neurons depleted of kinesin-5 actu-
ally continued to grow in the presence of noc-7, which virtually 
never occurred in the case of the controls (Fig. 3, A and B). On 
average, neurons treated with control siRNA retracted their axons 
29.5 ± 2.87 μm after 30-min exposure to noc-7, whereas neu-
rons depleted of kinesin-5 retracted their axons 19.8 ± 2.45 μm 
(mean ± SEM, P = 0.011; Fig. 3 C). Thus depletion of kinesin-5 
reduces the distances over which the axons would normally 
have retracted. Similar results were obtained with monastrol 
(unpublished data).
Effects of kinesin-5 depletion on axonal 
transport of short microtubules
For studies on microtubule transport (Fig. 4 A), the culture 
regimes were the same as for the morphological studies, except 
that replating was performed at 60 h after transfection, and cells 
Figure 2.  Axonal branching is enhanced when kinesin-5 is depleted. 
(A and B) DIC images of typical control (A) and kinesin-5–depleted (B) neu-
rons. Note the increase in branch number in axons depleted of kinesin-5. 
(C) Quantitative analysis of axonal branch number (normalized to total ax-
onal length) revealed a statistically signiﬁ  cant increase when compared 
with control siRNA–treated neurons (mean ± SEM; control siRNA = 0.006 ± 
0.002, kinesin-5 siRNA = 0.022 ± 0.002; *, P = 5.76 × 10
−8). 
(D) Categorical analysis at various branching loci (control siRNA, n = 27; 
kinesin-5 siRNA, n = 37) revealed a statistically signiﬁ  cant increase in 
branching frequency at all branch positions (mean ± SEM; primary 
branch: control = 0.006 ± 0.002, kinesin-5 siRNA = 0.013 ± 0.002, *, 
P < 0.02; secondary branch: control = 0.002 ± 0.001, kinesin-5 siRNA = 
0.004 ± 0.001, *, P < 0.03; tertiary branch: control = 0.001 ± 0.0004, 
kinesin-5 siRNA = 0.003 ± 0.001, *, P < 0.03; quaternary branch: 
control = 0.00 ± 0.00, kinesin-5 siRNA = 0.001 ± 0.0005, *, P < 0.007). 
Bars, 20 μm.
Figure 3.  Depletion of kinesin-5 reduces the distance of axonal retraction. 
(A and B) DIC images of control axons (A) and kinesin-5–depleted axons 
(B) before and 30 min after treatment with 0.3 mM noc-7. (B) Kinesin-5–
  depleted axons continue to elongate even in the presence of noc-7. Arrows 
demarcate the distal tips of growth cones before and after noc-7 treatment. 
(C) Quantitative analysis of noc-7–induced axonal retraction revealed a 
statistically signiﬁ  cant reduction in mean distance retracted in neurons de-
pleted of kinesin-5 (mean ± SEM; control, n = 54; kinesin-5 siRNA, n = 55; 
*, P = 0.011). Bar, 20 μm.JCB • VOLUME 178 • NUMBER 6 • 2007  1084
were allowed to grow axons for 12–16 h before imaging. These 
times were used because they coincide with the depletion of 
kinesin-5 via siRNA (Fig. 1 A) and because this period of incuba-
tion is optimal for EGFP-tubulin expression in these cells. For 
control siRNA, the total number of movements was 121 over a 
period of 105 min of image acquisition, with 79 in the antero-
grade direction and 42 in the retrograde direction. For kinesin-5 
siRNA, the total number of movements over 105 min of imaging 
was 216, representing the sum of 142 movements in the antero-
grade direction and 74 movements in the retrograde direction. 
With respect to transport directionality, these data represent a 
179% increase over controls in anterograde movement frequency, 
and a 176% increase over controls in retrograde movement fre-
quency, both statistically signifi  cant increases (anterograde, 
P ≤ 0.01; retrograde, P ≤ 0.025; χ
2; Fig. 4 B). Enhanced 
frequencies of short microtubule transport were also observed 
when monastrol was used to inhibit kinesin-5 activity, and these 
changes were comparable to the siRNA experiments (Fig. 4 C). 
For the monastrol studies, there was a 178% increase in antero-
grade transport frequency and a 172% increase in retrograde 
transport frequency (anterograde, P < 0.001; retrograde, P < 
0.001; χ
2). These results suggest that kinesin-5 imposes limitations 
on the number of short microtubules that are in transit (in both 
directions) within the axon.
To investigate whether this effect on transport is specifi  c to 
microtubules, we added fl  uorescently labeled markers of either 
vesicles or mitochondria and analyzed their movements under 
control- and kinesin-5–inhibited conditions. Using a rhodamine–
dextran tracer to monitor pinocytosed vesicular transport (Fig. 
5 A), we found that there was no statistical variation in axonal 
vesicle traffi  cking under conditions of kinesin-5 depletion in ei-
ther the distance or direction that the moving vesicles were trans-
ported (anterograde, P = 0.232; retrograde, P = 0.431; two-tailed 
t test; Fig. 5 B). We next investigated the effects of kinesin-5 
depletion on the axonal transport of mitochondria using the mito-
tracker label, which is a fl  uorescent label that is specifi  c for 
mitochondria (Buckman et al., 2001). For these experiments we 
measured both the length of the mitochondria, as well as the dis-
tance moved during the imaging period. Stationary mitochondria 
were not analyzed, although there was no noticeable difference 
between the numbers of stationary mitochondria between con-
trol and kinesin-5–depleted neurons (unpublished data). Similar 
to our studies of vesicle transport, no statistical difference was 
found when mitochondrion lengths were compared between con-
trol and kinesin-5–depleted axons (P = 0.08, two-tailed t test). 
Analysis of mitochondrion transport distances revealed a similar, 
nonsignifi  cant variation between control and kinesin-5–depleted 
specimens (P = 0.677, two-tailed t test; Fig. 5, C and D). These 
data are consistent with the effects of kinesin-5 on axonal 
transport being specifi  c to the transport of microtubules.
Depletion of kinesin-5 accelerates 
axonal growth by decreasing stepwise 
retraction events
Live-cell movies were used to further investigate the effects of 
depleting kinesin-5 on axonal length. Phase-contrast images 
were acquired for 5 h at 3-min intervals beginning 2 h after the 
neurons were replated. Consistent with the still images (Figs. 
1 and 2), the movies show that axons depleted of kinesin-5 grow 
more rapidly and undergo dramatic increases in branching as 
compared with controls (Fig. 6 A). The movies indicate that 
these effects are due, at least in part, to diminution in retraction 
events that normally accompany axonal development. Control 
neurons undergo relatively consistent bouts of growth and re-
traction, with the net result being axonal elongation. In contrast, 
kinesin-5–depleted neurons undergo substantially fewer bouts 
of retraction, resulting in enhanced stepwise growth. Analysis of 
the data indicates a signifi  cant change in the distribution of 
Figure 4.  Depletion of kinesin-5 enhances the transport frequency of short 
microtubules. (A) Time-lapse images of a neuron expressing GFP-tubulin re-
veal a short microtubule moving in the anterograde direction through a 
photobleached axon. White arrows mark the leading and trailing ends of 
the microtubule. (B) Quantiﬁ  cation of short microtubule transport frequency 
using siRNA-based depletion of kinesin-5 resulted in the increased fre-
quency of bidirectional short microtubule transport (anterograde: control 
siRNA, 0.752 events/min; kinesin-5 siRNA, 1.35 events/min; retrograde: 
control siRNA, 0.400 events/min; kinesin-5 siRNA, 0.705 events/min; 
*, P ≤ 0.025). (C) Inhibition of kinesin-5 with monastrol produced a result 
similar to siRNA-based depletion of kinesin-5, with an increase in bidirec-
tional transport frequency to levels approximately twofold higher than 
  observed in control neurons (anterograde: DMSO, 0.801 events/min; 
monastrol, 1.438 events/min; retrograde: DMSO, 0.458 events/min; 
monastrol, 0.788 events/min; *, P < 0.01). Bar, 5 μm.KINESIN-5 IS A BRAKE ON AXONAL MICROTUBULES • MYERS AND BAAS 1085
growth steps and retraction steps between control neurons and 
neurons depleted of kinesin-5 (control, n = 13; kinesin-5 siRNA, 
n = 13; P ≤ 0.001; χ
2) (Fig. 6, B and D). The effect on retraction 
was even more dramatic with regard to the stepwise movements of 
axonal branches, commonly resulting in branches that retracted 
entirely back into the primary axon (control, n = 8;   kinesin-5 
siRNA, n = 13; P ≤ 0.001; χ
2; Fig. 6 C and Video 1, available 
at http://www.jcb.org/cgi/content/full/jcb.200702074/DC1). Of 
the 198 stepwise movements measured in control branches, 112 
were growth oriented, whereas 68 were retractile, and the re-
maining 18 constituted time points when the axon did not grow 
or retract (neutral steps). In neuronal branches that had been 
  depleted of kinesin-5, a total of 356 stepwise movements were 
recorded, the sum of 298 growth-oriented, 34 retractile, and 
24 neutral steps (Fig. 6 E). Thus, it appears that depletion of 
  kinesin-5 results in enhanced frequencies of axonal branching 
by causing the axon to retract branches less frequently, thus 
  allowing greater numbers of branches to persist.
The effects of kinesin-5 overexpression 
are the inverse of kinesin-5 depletion
We wished to further test the specifi  city of our results by ascer-
taining whether an increase in kinesin-5 produces the inverse 
  effect of depletion. To investigate this, neurons were transfected to 
express either GFP alone (control) or to express EGFP–kinesin-5, 
after which they were replated and allowed to grow axons for 
7 h, as described for the siRNA experiments. For these ex-
periments, we used mCherry-tubulin to visualize microtubule 
transport. Investigations of mean axonal length in GFP control 
neurons (n = 20) were analyzed at 3, 5, and 7 h after replating. 
Axons were found to be of similar lengths to controls from 
siRNA-based experiments from respective time points (mean ± 
SEM; GFP control, 3 h = 64.5 ± 10.2 μm, 5 h = 108 ± 16.1 μm, 
7 h = 205 ± 21.3 μm). Consistent with the prediction of adding 
a large number of additional kinesin-5 molecules, the most 
highly expressing neurons displayed very short axons (typically 
<30 μm; Fig. 7 B). Comparison of axonal lengths of the low 
expressers (n = 21; Fig. 7 A) revealed a statistically signifi  cant 
decrease in mean axonal length when compared with GFP con-
trols at all three observed time points (3 h, P < 0.004; 5 h, P < 
0.004; 7 h, P < 0.0005; two-tailed t test; Fig. 7 C). When nor-
malized to controls, these reductions represent a decrease of 
252, 225, and 209% (at 3, 5, and 7 h, respectively) in the mean 
axonal lengths of neurons expressing EGFP–kinesin-5.
We next analyzed microtubule transport in the axons of 
the low expressers (Fig. 7 A). Analysis of GFP control neurons 
revealed frequencies of short microtubule transport that did not 
differ signifi  cantly from control siRNA–treated transport fre-
quencies. For GFP control axons, the total number of move-
ments was 93, with 60 in the anterograde direction and 33 in the 
retrograde direction over a period of 77 min of image acquisi-
tion. For EGFP–kinesin-5–expressing neurons, the total num-
ber of movements was 82, with 40 in the anterograde direction 
and 42 in the retrograde direction over 98 min of image acquisi-
tion. The decrease in transport was statistically signifi  cant, but 
only in the anterograde direction, where EGFP–kinesin-5 ex-
pression reduced transport by 190% (anterograde, P ≤ 0.01; 
retrograde, P ≤ 1; χ
2; Fig. 7 D). These results further demon-
strate the capacity of kinesin-5 to restrict the number of micro-
tu  bules in transit, but suggest that kinesin-5 may have a preference 
for restricting transport in the anterograde direction. There were 
no notable effects on microtubule bundling or organelle distri-
bution associated with the overexpression of kinesin-5 at these 
levels (unpublished data).
Kinesin-5 elicits its effects in a force-
dependent manner
It is noteworthy that monastrol-based inhibition of kinesin-5 
produced indistinguishable results from siRNA-based depletion 
of kinesin-5 in all of our studies on axonal morphology (Fig. 8) 
and microtubule transport (Fig. 4). Monastrol functions as an 
allosteric inhibitor of the motor by preventing the release of 
ADP bound to kinesin-5 (Lockhart and Cross, 1996). The func-
tional outcome of this allosteric inhibition is the locking of the 
kinesin-5 motor in a weak and diffusible microtubule-binding 
state, capable of eliciting a reduced and passive drag against micro-
tubules in motility assays (Crevel et al., 2004). Thus, treatment 
with monastrol would eliminate the force-generating properties 
of kinesin-5 but would presumably not eliminate other prop-
erties of kinesin-5, such as its capacity to passively interact with 
Figure 5.  Depletion of kinesin-5 motor does not affect axonal transport of 
membranous elements. (A) Time-lapse images of rhodamine-dextran–
labeled vesicles being transported retrogradely within the axon. White 
  arrows demarcate two mobile vesicles observed during the period of 
imaging. (B) Quantiﬁ  cation of vesicular transport direction and frequency 
revealed no difference between control and kinesin-5–depleted neurons 
(mean ± SEM; anterograde: control = 0.983 ± 0.357, kinesin-5 = 1.33 ± 
0.262; retrograde: control = 1.32 ± 0.201, kinesin-5 = 1.19 ± 0.206) 
(control axons, n = 14; kinesin-5–depleted axons, n = 14). (C) Analysis of 
mitochondrion transport revealed that the depletion of kinesin-5 does not 
have an effect on mitochondrion length (mean length ± SEM; control = 
3.10 ± 0.232 μm, kinesin-5 siRNA = 2.55 ± 0.206 μm) or distance of 
transport (mean ± SEM; control = 3.91 ± 1.05 μm, kinesin-5 siRNA = 
3.37 ± 0.742 μm) (control siRNA, n = 38; kinesin-5 siRNA, n = 39). 
(D) Time-lapse images of a mitotracker FM–labeled mitochondrion being 
transported anterogradely within the axon. Arrowheads mark the moving 
mitochondrion. Bars, 5 μm.JCB • VOLUME 178 • NUMBER 6 • 2007  1086
Figure 6.  Kinesin-5 depletion results in fewer bouts of retraction of axons and axonal branches. (A) Time-lapse, phase-contrast images of a control (left) 
and a kinesin-5–depleted neuron (right). Notice that whereas control axons form early branches, the branches typically undergo retraction events (left, 
  arrows). Kinesin-5–depleted branches display robust growth and are typically observed to elongate (right, arrows). (B) Quantitative comparison of axonal 
growth proﬁ  les revealed a signiﬁ  cant shift toward stepwise bouts of growth in axons depleted of kinesin-5 (*, P ≤ 0.001; χ
2). (C) Analysis of branching 
proﬁ  les revealed a similar and signiﬁ  cant shift toward stepwise bouts of growth when kinesin-5 was depleted (*, P ≤ 0.001; χ
2). (D and E) Data distribution 
graphs of the stepwise growth/retraction of control and kinesin-5–depleted axons (D) and branches (E). Bars, 20 μm. KINESIN-5 IS A BRAKE ON AXONAL MICROTUBULES • MYERS AND BAAS 1087
neighboring microtubules and potentially displace other motors, 
preventing them from interacting with the microtubules. There-
fore, it would appear that kinesin-5 must elicit forces in order 
for it to exert its regulatory effects on axonal growth. To further 
test this, we expressed in cultured neurons either a wild-type 
EGFP–kinesin-5 construct or an EGFP-labeled ATPase rigor 
mutant of kinesin-5 (T112N point mutant). Originally studied 
by Blangy et al. (1998), this mutation blocks ATP hydrolysis, 
locking the kinesin-5 motor in a strong microtubule-binding 
state that is able to promote microtubule–microtubule inter-
actions, but is unable to generate forces against microtubules. In 
conducting these experiments, we decided to perform them on 
neurons that had been treated with either control or kinesin-5 
siRNA. This experimental approach allowed us to test whether 
the observed effects on axonal growth require the force-generat-
ing properties of the motor and also provided an opportunity to 
conduct an additional control regarding the specifi  city of the re-
sults observed with siRNA-based depletion of kinesin-5. EGFP 
fl  uorescence intensity was used to ensure that we compared 
similarly expressing cells in each experimental group. There 
was some initial concern that the kinesin-5 siRNA that persisted 
in the cells might impede our capacity to express the EGFP–
kinesin-5 at suffi  ciently high concentrations to elicit an effect, 
but this did not prove to be a problem. The results of these ex-
periments are shown in Fig. 8.
Expression of the wild-type kinesin-5 in neurons treated 
with control siRNA confi  rmed our earlier overexpression data 
(Fig. 7 C), resulting in axonal lengths that were signifi  cantly 
shorter than neurons expressing endogenous levels of kinesin-5 
(control siRNA alone, mean ± SEM = 187 ± 37.1 μm; control 
siRNA + wild-type kinesin-5, 121 ± 29.9 μm; P < 0.008, two-
tailed t test). This effect was not observed in control siRNA–
treated neurons expressing the rigor mutant. Rather, under these 
conditions, expression of the rigor mutant kinesin-5 produced 
mean axonal lengths nearly identical to control cells (control 
siRNA + rigor mutant, mean ± SEM = 171 ± 58.2 μm; control 
siRNA alone, 187 ± 37.1 μm; P = 0.471, two-tailed t test).
Rescue of kinesin-5–depleted neurons with the wild-type 
construct resulted in axonal lengths that were statistically simi-
lar to neurons treated with control siRNA alone after 7 h of 
growth (wild-type rescue, mean ± SEM = 257 ± 46.1 μm; 
control siRNA alone, 187 ± 37.1 μm; P > 0.05, two-tailed 
t test). When the rigor mutant was introduced into kinesin-5– de-
pleted neurons, mean axonal lengths were observed to be statis-
tically indistinguishable from those recorded in neurons treated 
with monastrol or kinesin-5 siRNA alone (rigor mutant rescue, 
mean ± SEM = 546 ± 86.5 μm, n = 17; monastrol, 722 ± 
97.9 μm, n = 17; kinesin-5 siRNA alone, 774 ± 120 μm, n = 
21; P = 0.135, two-tailed t test). Moreover, when compared 
with other experimental treatments, axonal lengths in the rigor 
mutant rescue group persisted at levels twice as long as the 
wild-type rescue group, and nearly three times longer than neu-
rons treated with control siRNA alone (wild-type rescue, 257 ± 
46.1 μm, P < 0.02; control siRNA alone, 187 ± 37.1 μm, P < 
0.001, two-tailed t test; Fig. 8). These data indicate that the 
force-generating properties of kinesin-5 are central to its capac-
ity to restrict axonal lengths.
Figure 7.  Axonal growth and microtubule transport frequency are 
  affected by kinesin-5 overexpression. (A and B) DIC (top) and correspond-
ing anti-GFP immunocytochemistry (bottom) in neurons transfected with a 
wild-type EGFP–kinesin-5 construct demonstrating that axon length is co-
ordinated with the level of EGFP–kinesin-5 expression. (C) Quantitative 
analysis of mean axonal length revealed a statistically signiﬁ  cant reduction 
in mean axonal length in neurons expressing EGFP–kinesin-5 when compared 
with GFP control axons (mean ± SEM; EGFP–kinesin-5: 3 h = 25.6 ± 
6.38 μm, 5 h = 48.1 ± 10.7 μm, 7 h = 98.1 ± 18.2 μm; *, P < 0.0005). 
(D) Analysis of short microtubule transport frequency in EGFP–kinesin-5 
expressers revealed a signiﬁ  cant reduction in anterograde transport, but no 
change in retrograde transport frequency (mean ± SEM; anterograde: GFP 
control = 0.779 ± 0.041 events/min; EGFP–kinesin-5 = 0.408 ± 0.016 
events/min; retrograde: GFP control = 0.429 ± 0.033 events/min; 
EGFP–kinesin-5 = 0.449 ± 0.017 events/min; *, P ≤ 0.01). Bars, 30 μm. JCB • VOLUME 178 • NUMBER 6 • 2007  1088
Discussion
We previously speculated that kinesin-5 might be the motor that 
transports microtubules retrogradely in the axon, based on the 
premise that axonal growth rates may be determined by the ratio 
of anterograde/retrograde microtubule transport (Haque et al., 
2004; Baas et al., 2006). In this view, depleting kinesin-5 would 
cause axons to grow faster because of a marked increase in this 
ratio. However, the current results show something quite differ-
ent, i.e., that the frequency of microtubule transport in both 
  directions is markedly increased when kinesin-5 is depleted. 
These results indicate that kinesin-5 is not the motor that trans-
ports microtubules retrogradely. Instead, it appears that kinesin-5 
restricts the transport of short microtubules by other motors. 
The results of the depletion studies (Fig. 4) suggest that there is 
no directional preference on this effect, as removing kinesin-5 
results in marked increases in both directions. In this sense, it 
may not be the ratio of anterograde/retrograde transport that is 
most critical to axonal growth, but rather, the overall vitality of 
the transport. The overexpression studies (Fig. 7), however, 
raise the possibility of a directional preference, suggesting that 
kinesin-5 may be more suited to opposing microtubule transport 
in the anterograde direction. This possibility is consistent with 
other studies in which kinesin-5 was shown to antagonize minus 
end–directed motors such as cytoplasmic dynein and kinesin-14a 
(Gaglio et al., 1996; Walczak et al., 1998; Mountain et al., 1999; 
Tao et al., 2006). It may be that kinesin-5 restricts microtubule 
transport in both directions, but preferentially in the antero-
grade direction.
Additional observations suggest that the greater length of 
kinesin-5–depleted axons is not solely explicable (or even prin-
cipally explicable) on the basis of the changes in microtubule 
transport. The axons depleted of kinesin-5 are also far less prone 
to retraction, and this appears to be a major factor in their capac-
ity to achieve greater lengths. This phenomenon is particularly 
evident with regard to the greater number of branches displayed 
by axons depleted of kinesin-5, where the numbers of branches 
appear to be dependent on the propensity of newly formed 
branches to retract. This is important because the proclivity 
of the axon to retract is not regulated by short microtubules, 
but rather by the microtubules that are long enough to act as 
compression-bearing struts (He et al., 2002; Baas et al., 2006; 
Myers et al., 2006b). Thus, we would contend that kinesin-5’s 
principal role in regulating axonal length may be to infl  uence the 
balance of forces on the long microtubules, which is consistent 
with our overall view that the various motors that transport 
  microtubules are not selective for short microtubules but rather 
impinge upon microtubules of all lengths (Baas et al., 2006).
How does kinesin-5 elicits these effects? In the mitotic 
spindle, kinesin-5 is known to act between microtubules of op-
posite polarity orientation (interpolar microtubules). Although 
kinesin-5 was originally believed to function mainly to assist in 
the separation of the half spindles, newer studies indicate that it 
can alternatively function to resist separation of the half spindles 
by other motor proteins (Kapitein et al., 2005; Tao et al., 2006; 
Saunders et al., 2007). In this newer role, kinesin-5 has recently 
been likened to a brake on the microtubules within the spindle 
because it acts as a rate-limiting factor on the ability of the micro-
tubules to slide relative to one another. The analogy of kinesin-5 
acting as a brake on microtubule sliding is also quite applicable 
to our observations on the axon. The difference is that the mitotic 
spindle consists of regions of uniform and nonuniform micro-
tubule polarity orientation, whereas nearly all of the microtubules 
in the axon are thought to be of the same orientation (Baas, 1998; 
Figure 8.  Kinesin-5 elicits it effects in a force-dependent manner. Inhibition of kinesin-5 by monastrol treatment or depletion of kinesin-5 by siRNA produces 
mean axonal lengths that are approximately four times greater than neurons treated with DMSO (control) or control siRNA. When a wild-type kinesin-5 
construct is introduced into control siRNA–treated neurons, there is a corresponding diminution in mean axon length. Parallel experiments using a rigor mu-
tant (T112N) kinesin-5 construct in control siRNA–treated neurons revealed that mean axonal lengths were indistinguishable from the control siRNA alone 
group. A similar effect was observed in kinesin-5–depleted neurons that were rescued by introduction of the wild-type EGFP–kinesin-5, with mean axonal 
lengths that were statistically similar to control siRNA neurons expressing endogenous levels of the motor protein (mean ± SEM, wild-type rescue = 257 ± 
46.1 μm; control siRNA alone, 187 ± 37.1 μm; P > 0.05; two-tailed t test). Finally, in kinesin-5–depleted neurons that we attempted to rescue with the 
EGFP–kinesin-5 mutant, the mean length of axons were found to be nearly three times longer than the control siRNA–treated group, and more than twice 
the length of kinesin-5–depleted neurons rescued with wild-type kinesin-5 (mean ± SEM, rigor mutant rescue = 546 ± 86.5 μm; wild-type rescue, 257 ± 
46.1 μm; P < 0.002; control siRNA alone, 187 ± 37.1 μm, P < 0.001; two-tailed t test). *, P < 0.02. KINESIN-5 IS A BRAKE ON AXONAL MICROTUBULES • MYERS AND BAAS 1089
Hasaka et al., 2004). Thus it remains unclear whether the mecha-
nism underlying the kinesin-5 brake is the same in the axon as in 
the mitotic spindle or one that is quite different.
It is important to note that kinesin-5 can also generate 
forces between neighboring microtubules of the same orienta-
tion within the mitotic spindle (Kapoor et al., 2000). Indeed, some 
of the earliest studies indicating antagonism between kinesin-5 
and minus-end directed motors were conducted on monoasters of 
uniform polarity orientation (Gaglio et al., 1996). More recent 
studies suggest a complexity of possibilities for how kinesin-5 
is able to generate different kinds of forces between micro-
tubules of the same or different polarity orientations (Kapetein 
et al., 2005; Saunders et al., 2007). One possibility is that the 
two ends of the homotetramer are not always in synchrony with 
regard to force generation, thus generating options for the manner 
by which forces impact the relevant microtubules. It appears 
that kinesin-5 is also quite different from other kinesins with 
  regard to how it reacts to changes in load (Valentine et al, 2006), 
which would likely infl  uence kinesin-5’s force-dependent func-
tions. Whatever the case, understanding the complexities of 
force generation by kinesin-5 may clarify how kinesin-5 is 
capable of opposing transport of microtubules in both directions 
within the axon.
In discussing its mechanism of action, it is also important 
to consider that not all of the properties of kinesin-5 are force 
dependent. Kinesin-5 has been observed to cross-link neighbor-
ing microtubules (Sharp et al., 1999a) and to do so in a passive 
manner that does not require ATP (Tao et al., 2006). In this sense, 
kinesin-5 could antagonize microtubule sliding simply by cross-
linking adjacent microtubules or by displacing other motors 
from the microtubule lattice, even when kinesin-5 is not under-
going a power stroke. Our studies using the rigor mutant indicate 
that the force-dependent properties of kinesin-5 are required for 
it to elicit its effects on axonal growth. Even so, we are reluctant 
to completely dismiss the possibility that the force-independent 
properties of kinesin-5 might contribute to its functions in the 
axon. For example, the growth cones of kinesin-5–depleted ax-
ons are clearly broader than those of control axons (Fig. 6), sug-
gesting that the microtubules within these growth cones may be 
less cross-linked in the absence of kinesin-5. Thus it may be that 
the dual properties of kinesin-5 are manifested differently in the 
growth cone and in the axonal shaft. In this regard, it will be 
prudent in the future to conduct studies with the rigor mutant 
specifi  cally on growth cone behaviors.
Another open question is whether kinesin-5 opposes all 
other motors equally, or if kinesin-5 specifi  cally or preferen-
tially antagonizes minus end–directed motors in the neuron. We 
have not yet studied kinesin-14a in neurons, but we have con-
ducted a great deal of work on cytoplasmic dynein. As noted in 
the Introduction, these studies have enabled us to propose a 
model whereby cytoplasmic dynein generates forces between 
the longer microtubules in the axon and the cortical actin mesh-
work. These dynein-driven forces antagonize the contractile 
forces imposed on the cortical actin array by myosin-II (Ahmad 
et al., 2000; Myers et al., 2006b). Our fi  nding that kinesin-5 
promotes axonal retraction is consistent with a scenario by which 
forces generated by kinesin-5 antagonize the forces generated 
by cytoplasmic dynein. Our tentative thinking is that the micro-
tubules nearest the cortex interact with the cortical actin via cyto-
plasmic dynein, and that these same microtubules sometimes 
interact with adjacent microtubules via kinesin-5. When the 
kinesin-5 is engaged there is an increase in the load on the cyto-
plasmic dynein, thereby attenuating its ability to antagonize the 
contractility of the cortical actin.
Clearly, an important goal for the future will be to further 
test the various possibilities of exactly how kinesin-5 elicits 
such a profound role in restricting the growth of the axon. In 
addition to elucidating its mechanism of action, an even more 
important question may be to ascertain why it is that developing 
neurons express such a potent brake on the growth potential of 
their axons. Also, of course, the question remains as to how 
kinesin-5’s functions are regulated within the axon. In particu-
lar, local regulation of kinesin-5 would enable the axon to in-
crease or decrease the relevant forces to comply with the needs 
of the axon. For example, branch formation would benefi  t both 
from a local increase in short microtubule transport and from a 
diminished propensity of the branch to retract once long micro-
tubules have been established in the branch. This kind of regula-
tion could be accomplished by signaling pathways, given that 
the association of kinesin-5 with microtubules is regulated by 
phosphorylation (Blangy et al., 1995; Sawin and Mitchison, 
1995). Finally, it will be important to ascertain whether our 
fi  ndings on kinesin-5 apply to adult axons as well as developing 
axons because the ability to enhance axonal growth so dramati-
cally by inhibiting kinesin-5 could be a powerful tool for aug-
menting axonal regeneration after injury (Baas, 2002).
Materials and methods
Cell culture and transfection
Cultures of dissociated neurons from rat superior cervical ganglia were 
prepared as previously described (He et al., 2005). For experiments using 
siRNA, dissociated neurons were transfected with 10 μM (ﬁ  nal concentra-
tion) of either control siRNA or kinesin-5 siRNA (Silencer KIF11 [Eg5] 
siRNA; Ambion). Once transfected, the neurons were cultured in L-15 me-
dium on 35-mm plastic dishes that had been coated with 0.1 mg/ml poly-
D-lysine (PDL) for 3 h and repeatedly rinsed in double-distilled H2O. The 
following morning 5 μg/ml laminin and 5 μM arabinose C were added to 
the culture medium. For transport studies, the neurons were replated (He 
et al., 2005) at a density of  7,500 cells/dish at 60 h after transfection 
onto grided glass coverslips that had been coated with 0.1 mg/ml PDL and 
25 μg/ml laminin. Replating was performed 72 h after transfection. The 
EGFP-tubulin construct (CLONTECH Laboratories, Inc.) and the mCherry-
  tubulin construct (provided by R. Tsien, University of California, San Diego, 
La Jolla, CA) were transfected at 15 μg. Wild-type and mutant kinesin-5 
constructs were provided by M. Kress (Institut André Lwoff, Centre National 
de la Recherche Scientiﬁ  que, Villejuif, France) and A. Blangy (Centre de 
Recherches en Biochimie Macromoléculaire, Centre National de la   Recherche 
Scientiﬁ   que Unité Propre de Recherche, Montpellier, France), and then 
  engineered in our laboratory as fusions with EGFP. The mutant construct, 
termed T112N, is described in detail by Blangy et al. (1998). For kinesin-5 
overexpression studies, 12 μg of either GFP (control) or EGFP–kinesin-5 
was cotransfected with mCherry-tubulin.
In one study, we wished to determine if expression of wild-type and/
or the mutant kinesin-5 could “rescue” the phenotype obtained with siRNA-
based depletion of kinesin-5. For these experiments, neurons were ﬁ  rst trans-
fected with siRNA. 48 h after transfection with siRNA, either the wild-type 
EGFP–kinesin-5 or the rigor mutant EGFP–kinesin-5 (T112N) was introduced 
using Lipofectamine 2000 (Invitrogen) as previously described (Yu et al., 
2005), except that Lipofectamine treatments were performed for 4.5 h 
duration and were followed by rinsing and medium replacement with L-15 
plating medium. Neurons were then replated 24–30 h after Lipofectamine JCB • VOLUME 178 • NUMBER 6 • 2007  1090
treatment and morphological analysis was performed as described below 
for siRNA experiments. Expression was observed in  15–20% of neurons, 
and data analysis used neurons with expression levels greater than the 
mean expression value (determined by arbitrary ﬂ  uorescence units) for that 
experimental group.
Immunological techniques and Western blotting
See the online supplemental Materials and methods.
Morphological studies
For all morphological investigations, neurons were cultured and replated 
after the 72-h replating regimen. For axonal length and branching experi-
ments, neurons were identiﬁ  ed at 1 h after replating (before they had estab-
lished axons). The neurons were then imaged sequentially at 3, 5, and 7 h 
after replating. Axonal lengths were measured using the “measure/curve” 
application of Axiovision LE 4.5 (Carl Zeiss MicroImaging, Inc.), and mean 
values were quantiﬁ  ed. Analysis of branching frequency was performed by 
counting the total number of branches per neuron and dividing these values 
by total axonal length for individual neurons. For both total branching and 
categorical branching analysis, we used normalization of branch number to 
total axonal length to ensure accurate evaluation of branching frequency.
Nitric oxide–induced axonal retraction
60 h after transfection with control or kinesin-5 siRNA, neurons were re-
plated onto gridded PDL (0.1 mg/ml) and laminin-treated (25 μg/ml) 
glass-bottom culture dishes. By 72 h the neurons had generated extensive 
axons. The nitric oxide donor, noc-7 (Calbiochem), was prepared and ap-
plied as previously described (He et al., 2002), except that it was used at 
a working concentration of 0.3 mM. DIC images of axons were recorded 
before and 30 min after addition of noc-7. Axonal lengths (from growth 
cone to cell body or to the ﬁ  rst bifurcation point) were measured using the 
“measure/curve” application in Axiovision LE 4.5. Raw data were pro-
cessed and graphs were produced using Excel (Microsoft Corp.).
Transport assays
The microtubule transport assay was performed essentially as described 
previously (Hasaka et al., 2004), except that for experiments using phar-
macological inhibition of kinesin-5 with monastrol, the neurons were plated 
directly onto glass coverslips in drug-containing medium and were imaged 
24–36 h later. For siRNA-based studies, neurons transfected with either 
control siRNA or kinesin-5 siRNA were replated at 60 h as described in the 
previous paragraph. A total of 211 time-lapse images were taken at 700–
900-ms exposure using 3-s intervals for each axon. Transport analysis in-
cluded all microtubules observed to move continuously through the 
photobleached region during the imaging period. Transport frequencies 
were calculated by dividing the total number of movements by the total 
imaging time for individual movies.
Vesicle and mitochondrion transport assays
See the online supplemental Materials and methods.
Live-cell imaging and analysis of stepwise axonal growth/retraction
Neurons transfection with control or kinesin-5 siRNA (see Cell culture and 
transfection) were replated in L-15 medium (supplemented with FBS) onto 
PDL- and laminin (25 μg/ml)-coated glass coverslips. The L-15 medium was 
coated with 2 ml of mineral oil (Sigma-Aldrich) as a means to prevent me-
dium evaporation and to maintain nutrient concentrations over time. Phase-
contrast time-lapse images were acquired using either a 40 or 20× objective 
lens with 700-ms exposure time and 1 × 1 binning. Image acquisition was 
performed at 3-min intervals for 5 h using a heated stage apparatus to 
maintain the temperature at 37°C. Stepwise axon and branch growth were 
analyzed using the “Apps/Track Points” application of Metamorph software 
(Molecular Devices) by establishing a point of origin and then using auto-
mated tracking of axonal outgrowth. Data were exported from Metamorph 
to Excel and were analyzed for the relative change in distance to origin. 
A camera (Orca ER; Hamamatsu) was used. For additional details on statisti-
cal analysis and image processing, see online supplemental materials.
Online supplemental material
Video 1 shows that kinesin-5 depletion results in fewer bouts of retraction 
of axons and axonal branches. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200702074/DC1.
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